GLO1 and Hyperglycemia: Conversely, inhibition of GLO1 with a specific GLO1 inhibitor, S-p-bromobenzylglutathione cyclopentyl diester (BBGSHCp2) led to accumulation of MG in low glucose concentration and dysfunction similar to that found in the hyperglycaemia model15.